Surely, we can’t be the first to take note. See news today about how Scottdale’s Medicis Pharmaceutical, which treats people who cannot stand their wrinkles, is buying Inamed, a breast-implant company, for $2.8 billion. (Maker of Wrinkle Treatment to Buy Breast Implant Leader) At least this isn’t a, um, valley company.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.
